OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway
Kun Qiao, Shipeng Ning, Lin Wan, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 158
Kun Qiao, Shipeng Ning, Lin Wan, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 158
Showing 1-25 of 158 citing articles:
MicroRNA: A signature for cancer progression
Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111528-111528
Open Access | Times Cited: 244
Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111528-111528
Open Access | Times Cited: 244
The biological implications of Yin Yang 1 in the hallmarks of cancer
Ian Timothy Sembiring Meliala, Rendy Hosea, Vivi Kasim, et al.
Theranostics (2020) Vol. 10, Iss. 9, pp. 4183-4200
Open Access | Times Cited: 102
Ian Timothy Sembiring Meliala, Rendy Hosea, Vivi Kasim, et al.
Theranostics (2020) Vol. 10, Iss. 9, pp. 4183-4200
Open Access | Times Cited: 102
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, et al.
Cancer Letters (2021) Vol. 507, pp. 112-123
Open Access | Times Cited: 83
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, et al.
Cancer Letters (2021) Vol. 507, pp. 112-123
Open Access | Times Cited: 83
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions
Rendy Hosea, Sharon Hillary, Shourong Wu, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3506-3506
Open Access | Times Cited: 31
Rendy Hosea, Sharon Hillary, Shourong Wu, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3506-3506
Open Access | Times Cited: 31
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Liemei Lv, Xiangxiang Zhou
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 24
Liemei Lv, Xiangxiang Zhou
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 24
TCONS_00012883 promotes proliferation and metastasis via DDX3/YY1/MMP1/PI3K‐AKT axis in colorectal cancer
Peng Yang, Jie Li, Chaofan Peng, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 61
Peng Yang, Jie Li, Chaofan Peng, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 61
LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR‐515‐5p/GINS2 axis
Guangcheng Dai, Chenchen Huang, Jinhui Yang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 16, pp. 9231-9243
Open Access | Times Cited: 58
Guangcheng Dai, Chenchen Huang, Jinhui Yang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 16, pp. 9231-9243
Open Access | Times Cited: 58
CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p
Kebin Zheng, Haipeng Xie, Wensong Wu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Kebin Zheng, Haipeng Xie, Wensong Wu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine
Farzad Sadri, Seyede fatemeh Hosseini, Zohreh Rezaei, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 760-771
Open Access | Times Cited: 17
Farzad Sadri, Seyede fatemeh Hosseini, Zohreh Rezaei, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 760-771
Open Access | Times Cited: 17
Glioma stem cell‐derived exosomes induce the transformation of astrocytes via the miR ‐3065‐5p /DLG2 signaling axis
Haoran Li, Jianjun Zhu, Xinglei Liu, et al.
Glia (2024) Vol. 72, Iss. 5, pp. 857-871
Closed Access | Times Cited: 6
Haoran Li, Jianjun Zhu, Xinglei Liu, et al.
Glia (2024) Vol. 72, Iss. 5, pp. 857-871
Closed Access | Times Cited: 6
Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies
Chou‐Yi Hsu, Ahmed Faisal, Sally Salih Jumaa, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 970-994
Open Access | Times Cited: 6
Chou‐Yi Hsu, Ahmed Faisal, Sally Salih Jumaa, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 970-994
Open Access | Times Cited: 6
The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
Chao Tu, Kexin Yang, Lu Wan, et al.
Cell Proliferation (2020) Vol. 53, Iss. 9
Open Access | Times Cited: 46
Chao Tu, Kexin Yang, Lu Wan, et al.
Cell Proliferation (2020) Vol. 53, Iss. 9
Open Access | Times Cited: 46
The network of non-coding RNAs and their molecular targets in breast cancer
Francesca Crudele, Nicoletta Bianchi, Eva Reali, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Francesca Crudele, Nicoletta Bianchi, Eva Reali, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
Mathias Cobbaut, Simge Karagil, Lucrezia Bruno, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 151-151
Open Access | Times Cited: 42
Mathias Cobbaut, Simge Karagil, Lucrezia Bruno, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 151-151
Open Access | Times Cited: 42
Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
Liyuan Peng, Jingwen Jiang, Bo Tang, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10360-10377
Open Access | Times Cited: 41
Liyuan Peng, Jingwen Jiang, Bo Tang, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10360-10377
Open Access | Times Cited: 41
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, et al.
Current Cancer Drug Targets (2021) Vol. 21, Iss. 8, pp. 640-665
Closed Access | Times Cited: 34
Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, et al.
Current Cancer Drug Targets (2021) Vol. 21, Iss. 8, pp. 640-665
Closed Access | Times Cited: 34
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
SIRT1 is transcriptionally repressed by YY1 and suppresses ferroptosis in rheumatoid arthritis
Yuwei Zhan, Yang Zhou, Feng Zhan, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 14
Yuwei Zhan, Yang Zhou, Feng Zhan, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 14
A novel long non-coding RNA SLNCR1 promotes proliferation, migration, and invasion of melanoma via transcriptionally regulating SOX5
Lele Cong, Qing Zhao, Hongyan Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Lele Cong, Qing Zhao, Hongyan Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression
Zhonghou Rong, Zhiyi Wang, Xinxing Wang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 36
Zhonghou Rong, Zhiyi Wang, Xinxing Wang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 36
Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR‐942‐5p and releasing DLG2 via Hippo‐YAP signaling
Shiquan Li, Guoqiang Yan, Wei Liu, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 12, pp. 1323-1342
Closed Access | Times Cited: 35
Shiquan Li, Guoqiang Yan, Wei Liu, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 12, pp. 1323-1342
Closed Access | Times Cited: 35
Circular RNA circPIP5K1A contributes to cancer stemness of osteosarcoma by miR-515-5p/YAP axis
Pengxu Shi, Yueting Li, Qing-sheng Guo
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Pengxu Shi, Yueting Li, Qing-sheng Guo
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 32
SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis
Yaxuan Zhang, Yin Zhang, Sen Wang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 2299-2310
Open Access | Times Cited: 29
Yaxuan Zhang, Yin Zhang, Sen Wang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 2299-2310
Open Access | Times Cited: 29
Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy
Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, et al.
Cellular Signalling (2022) Vol. 99, pp. 110434-110434
Closed Access | Times Cited: 21
Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, et al.
Cellular Signalling (2022) Vol. 99, pp. 110434-110434
Closed Access | Times Cited: 21
Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs
Uttam Sharma, Hardeep Singh Tuli, Vivek Uttam, et al.
Pharmacological Research (2022) Vol. 186, pp. 106523-106523
Closed Access | Times Cited: 21
Uttam Sharma, Hardeep Singh Tuli, Vivek Uttam, et al.
Pharmacological Research (2022) Vol. 186, pp. 106523-106523
Closed Access | Times Cited: 21
